Quality Matters? The Involvement of Mitochondrial Quality Control in Cardiovascular Disease

Abstract

Cardiovascular diseases are one of the leading causes of death and global health problems worldwide. Multiple factors are known to affect the cardiovascular system from lifestyles, genes, underlying comorbidities, and age. Requiring high workload, metabolism of the heart is largely dependent on continuous power supply via mitochondria through effective oxidative respiration. Mitochondria not only serve as cellular power plants, but are also involved in many critical cellular processes, including the generation of intracellular reactive oxygen species (ROS) and regulating cellular survival. To cope with environmental stress, mitochondrial function has been suggested to be essential during bioenergetics adaptation resulting in cardiac pathological remodeling. Thus, mitochondrial dysfunction has been advocated in various aspects of cardiovascular pathology including the response to ischemia/reperfusion (I/R) injury, hypertension (HTN), and cardiovascular complications related to type 2 diabetes mellitus (DM). Therefore, mitochondrial homeostasis through mitochondrial dynamics and quality control is pivotal in the maintenance of cardiac health. Impairment of the segregation of damaged components and degradation of unhealthy mitochondria through autophagic mechanisms may play a crucial role in the pathogenesis of various cardiac disorders. This article provides in-depth understanding of the current literature regarding mitochondrial remodeling and dynamics in cardiovascular diseases.

Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

“…To prevent and reduce mitochondrial dysfunction, the cell activates coordinated processes that constitute mitochondrial quality control: mitochondrial dynamics, biogenesis and mitophagy [ 6 , 7 ]. Mitochondrial biogenesis is the process of synthesis of new mitochondria, which is triggered by the transcription factor PPAR-gamma co-activator 1 alpha (PGC1α) after AMP-activated kinase (AMPK) activation.…”

Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease—Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors

“…Linkage between β-cell dysfunction and neurodegeneration during the aging process has been shown by studies with the purpose to clarify the interrelationship between glycometabolic derangement, mitochondrial dysfunction related oxidative stress, inflammatory response, and PD via investigating dietary effect on PD risk [87][88][89]. In agreement with this, the ketogenic diet containing very low carbohydrates was reported to be anti-inflammatory and neuroprotective against mitochondrial complex I inhibitors in both MPTP and 6-OHDA neurotoxic PD animal models [90,91]. Another study also suggested a dietary pattern consisting of high intakes of vegetables, fruits, and fish is associated with a decreased risk of PD in Japanese by measuring overall cumulative dietary pattern [92].…”

Unlocking the Complexity of Mitochondrial DNA: A Key to Understanding Neurodegenerative Disease Caused by Injury

“…Typically, a blood clot or plaque forms in an artery supplying the brain, thereby causing a blockage of blood flow to the brain. Blood restriction causes a decrease in oxygen and glucose to tissues, leading to mitochondrial dysfunction [ 93 , 94 ]. Increased mitochondrial dysfunction results in decreased oxidative metabolism and ATP, coupled with an increase in toxic reactive oxygen and nitrogen species (ROS and RNS).…”